REPORT DESCRIPTION
Alzheimer’s Drugs Market – Overview
Alzheimer’s is a form of dementia, which affect behavior, thinking, and memory of patient. The progression of
disease is slow and it degrades neurons associated with learning part of cerebrum. It is most common and largest
form of dementia (more than 60%), which is observed in people of age 65 and above. Accumulation of protein
called as beta amyloid in spaces between nerve cells due to genetic mutation is major cause of Alzheimer.
Although Alzheimer’s disease is not treatable, symptomatic treatment is followed in all cases. Research is being
carried out to develop treatment centered on the role of beta-amyloid in Alzheimer’s disease.
Increasing prevalence and incidence of Alzheimer’s disease worldwide is expected to drive the growth of
Alzheimer’s disease therapeutics market. According to World Alzheimer Report in 2016, an estimated 46.5
million people were suffering from Alzheimer’s disease and the number is projected to reach 50 million by 2017,
every three second there is new patient of Alzheimer’s disease worldwide.